Delivery Order SPE2DB22D3016-SPE2DB25FBDF3
- Not listed
- The Defense Logistics Agency awarded a $6,007.90 delivery order to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count) on April 24, 2025, with an ultimate completion date of May 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with...
- The Defense Logistics Agency awarded a $6,007.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count units) on September 3, 2025, with an ultimate completion date of September 24, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery order is to be fulfilled...
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed price contract. This non-competitive delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, will be performed at the awardee's facility in Conshohocken, Pennsylvania. Tasigna is a specialized oncology medication used in the treatment of certain types of leukemia, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed price contract with a ceiling value of $6,007.90 and an ultimate completion date of September 24, 2025. This is a non-set-aside, competitively awarded delivery order issued as a child contract against AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Tasigna 150 mg capsules (28-count units) with a ceiling value of $18,023.70. This firm fixed-price delivery order, with an ultimate completion date of October 15, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $18,023.70 to AmerisourceBergen Drug Corp for TASIGNA 150 MG capsules (28-count) on August 19, 2025. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Tasigna 150 mg capsules (28-count units) with a ceiling value of $6,007.90. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 29, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Tasigna 150 mg capsules (28-count units) with a ceiling value of $6,007.90. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement under the company's existing...
- The Defense Logistics Agency has awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for the supply of Tasigna 200 mg capsules (28-count packaging). This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (quantity: 28 units) on September 4, 2025. This firm fixed-price, competitively awarded delivery order is scheduled for completion by September 25, 2025, with fulfillment occurring at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, indicating that AmerisourceBergen competed...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDF3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (quantity: 28) under a firm fixed price contract. This delivery order is not set-aside and was competitively awarded. The contract is scheduled for completion by August 18, 2025, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tasigna is a prescription medication used in the treatment of chronic myeloid leukemia, representing the type of specialized pharmaceutical products that the Defense Logistics Agency procures to support military and veteran healthcare systems. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to military healthcare programs worldwide. AmerisourceBergen's established position as a major pharmaceutical distributor and its demonstrated capability to fulfill federal procurement requirements through open competition make the company a critical vendor for the Defense Logistics Agency's medical supply chain operations supporting Defense Health Agency customers and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 7/28/25 |